Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2011 May;12(5):341-55.
doi: 10.1038/nrg2988.

Therapeutic in vivo gene transfer for genetic disease using AAV: progress and challenges

Federico Mingozzi  1 , Katherine A High
Affiliations
Review

Therapeutic in vivo gene transfer for genetic disease using AAV: progress and challenges

Federico Mingozzi et al. Nat Rev Genet. 2011 May.

Erratum in

  • Nat Rev Genet. 2011 Jul;12(7):515

Abstract

In vivo gene replacement for the treatment of inherited disease is one of the most compelling concepts in modern medicine. Adeno-associated virus (AAV) vectors have been extensively used for this purpose and have shown therapeutic efficacy in a range of animal models. Successful translation to the clinic was initially slow, but long-term expression of donated genes at therapeutic levels has now been achieved in patients with inherited retinal disorders and haemophilia B. Recent exciting results have raised hopes for the treatment of many other diseases. As we discuss here, the prospects and challenges for AAV gene therapy are to a large extent dependent on the target tissue and the specific disease.

PubMed Disclaimer

References

    1. Blood. 1996 Nov 1;88(9):3451-5 - PubMed
    1. Nat Med. 2007 Apr;13(4):419-22 - PubMed
    1. Hum Gene Ther. 2002 Jul 20;13(11):1349-59 - PubMed
    1. Nat Genet. 1995 May;10(1):119-21 - PubMed
    1. N Engl J Med. 2009 Jul 9;361(2):161-9 - PubMed

Publication types